Critical Bottlenecks in Your GPCR Pipeline
❌ Overwhelming pharmacology Data
❌ Suboptimal CRO Partnerships
❌ Stalled Pipeline Progression
❌ Uncertainty in GPCR Investments
Advisory Focus Areas
Expert support for Biotech innovators, VC investors and CRO partners
Biotech Pipeline Acceleration
For Biotech Leaders & Scientists
-
Actionable Data Insights: Translate complex GPCR pharmacology into clear decisions for lead optimization and candidate selection.
-
Accelerated Program Progression: Design robust assay cascades and establish key go/no-go points to speed up your pipeline.
-
Optimized CRO Collaboration: Streamline internal R&D and external CRO workflows to prevent delays and ensure preclinical success.
VC Due Diligence & De-risking
For Venture Capital Firms
-
De-risk GPCR Investments: Identify critical scientific red flags and technical gaps in GPCR assets before committing capital.
-
Actionable Scientific Validation: Ensure target companies execute the right GPCR pharmacology experiments to generate robust, decision-making data.
-
Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic potential to inform investment strategy.
CRO Partnership & Optimization
For Contract Research Organizations
-
Elevate Scientific Offerings: Refine and optimize your GPCR assay platforms and in vitro models to deliver superior data quality and results.
-
Enhance Client Project Delivery: Streamline workflows and improve scientific execution to increase client satisfaction and secure repeat business.
-
Differentiate Your Market Position: Showcase your specialized GPCR expertise to stand out from competitors and attract high-value biotech and pharma partners.
How We Work: Your Path to GPCR Success
1
Initial Strategic Alignment
We begin with a focused discussion of your current GPCR program and critical challenges, identifying precise areas for collaboration.
2
Define Actionable Objectives
Together, we clarify specific, measurable goals, from target validation and assay development to CRO selection or portfolio strategy, ensuring a tailored approach.
3
Collaborative Execution & Impact
I integrate directly into your discovery process to remove roadblocks, enhance execution, and generate actionable scientific data, driving confident decisions and sustained preclinical progress.
My Approach: Precision Guidance for GPCR Programs
I provide the focused, scientific expertise that accelerates complex GPCR discovery programs, ensuring clarity and de-risking your path from target to candidate. I integrate seamlessly with biotech, VC, and CRO teams as a trusted, objective partner.
Integrated Strategic Partnership
We collaborate directly with your scientific and leadership teams. This partnership prevents bottlenecks and optimizes resource allocation, ensuring every strategic decision efficiently propels your program forward and aligns with critical business objectives.
Biology-First, Data-Driven Solutions
Every recommendation is rooted in GPCR biology, pharmacology experience. This provides evidence-based strategies leveraging deep GPCR expertise to overcome specific scientific challenges and maximize your program's potential.
Accelerated Preclinical Progression
I streamline critical operational processes, from advanced assay design and CRO management to rapid go/no-go decision-making. This focused execution accelerates preclinical milestones and maximizes the efficiency and return on your R&D investment.
Core Values: The Foundation of Every Successful Partnership
My advisory is built on principles that ensure clarity, minimize risk, and drive enduring results in GPCR drug discovery.
Scientific Integrity
Every recommendation is rigorously evidence-based, not reliant on assumptions. This ensures robust, defensible decisions that de-risk your program from early discovery to regulatory milestones.
Operational Discipline
I instill structure and consistency across every phase of your discovery process. This approach eliminates inefficiencies and standardizes workflows, accelerating your path to a preclinical candidate.
Collaborative Partnership
I operate as an embedded, invested partner with your team. Your program's success is my priority, fostering a transparent, results-driven environment that maximizes collective expertise and accelerates progress.
About Yamina A. Berchiche
I'm Yamina A. Berchiche, and I understand the intricate challenges of GPCR drug discovery. Small missteps can derail entire programs: underperforming assays, off-track CROs, and data that fails to drive decisions. That's precisely where my expertise becomes your strategic advantage.
With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector, I bring unparalleled scientific depth and operational precision to every project. My work focuses on integrating directly with your team as a strategic partner.
Whether it's optimizing CRO selection, building robust internal capabilities, or translating complex data into decisive program advancements, I help you eliminate friction, align efforts, and accelerate your path to success.
As the founder of Dr. GPCR, I also offer a unique, broad perspective and trusted relationships within the field. This allows me to connect you with critical insights and key collaborators, further accelerating your progress in GPCR drug discovery.
What Partners Say
Here’s what it’s like to work together — from people I’ve supported on both sides of the bench.
Anne Marie Quinn, CEO
Montana Molecular
As a CRO, we were delivering high-quality data across complex biotech programs, but translating that data into aligned, timely decisions across stakeholders wasn’t always straightforward.
After partnering with her, communication became clearer, deliverables were better defined, and collaboration across teams ran more smoothly.
She helped streamline complex projects and made the CRO–client relationship more effective and productive.
Terry Kenakin, PhD
UNC Chappel Hill
In complex pharmacological discovery programs, scientific ambiguity and fragmented execution can quietly erode progress. Yamina brings the clarity, rigor, and structured decision-making that keeps programs on track.
Across multiple discovery efforts, she established clear decision gates and alignment across teams, materially strengthening candidate progression and prioritization.
Her involvement consistently elevates both the scientific discipline and the quality of portfolio-level decisions.
Murat Tunaboylu, CEO
Antiverse
Before engaging Yamina, our team faced hurdles navigating complex early discovery decisions. We had critical program choices ahead and needed clearer direction.
Bringing her in marked a meaningful shift. We made confident progress on a pivotal program and gained clarity on our next strategic focus.
Yamina was instrumental in unifying our scientific and operational teams, strengthening alignment and driving momentum across execution.
Abishek Iyer, CEO
Ashta Therapeutics
Before working with Yamina, we had solid internal momentum but needed to better align our biology, assay priorities, and compound strategy into a cohesive, decision-driven plan.
Her input helped us structure the screening funnel, define clear go/no-go criteria, and integrate ADME and mechanistic assays in a way that reflected both biological rationale and operational realities.
She has been a true thought partner — not only on tactical execution, but on pressure-testing hypotheses, challenging assumptions, and maintaining disciplined forward progress.
Book My 30 Minutes Strategy Call
Ready to collaborate?
Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech, VC, and CRO teams.
©2023-2025 All rights reserved by FindYooour, LLC & Dr. GPCR Corp
Proudly created with Wix.com